Showing 2471-2480 of 8166 results for "".
BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianSpecial Report: COVID-19: Surgeons Support Front Lines, How to Cope
https://practicaldermatology.com/topics/practice-management/special-report-covid-19-surgeons-support-front-lines-how-to-cope/19757/The AAFPRS calls on surgeons to consider donating PPE and supplies like ventilators and beds, as nurses call for more preparation for COVID-19. Experts offer strategies for coping with the current environment and planning ahead. Although the AAD Annual Meeting has been cancelled, voting for new offiExploring the Benefits of Nitric Oxide for Hair Loss Patients Through REVIAN® Red
https://practicaldermatology.com/topics/hair-nails/exploring-the-benefits-of-nitric-oxide-for-hair-loss-patients-through-revian-red/19753/Learn more about the mechanism of action of the new REVIAN Red Dual-Band LED light therapy cap and what makes it unique from other at-home FDA-cleared devices. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton classifications of IIaJournal Club: Blocking IL-4/IL-13 vs JAK/STAT
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-blocking-il-4il-13-vs-jakstat/29101/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Editorial Board member Peter Lio, MD, about the Journal of Personalized Medicine article, "Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?"The First 5 Minutes with a Patient
https://practicaldermatology.com/series/pa-perspectives/first-5-minutes-patient/27105/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses the importance of crafting the right message during the first 5 minutes with a patient.Treating Non-melanoma Skin Cancer: What’s New and Exciting
https://practicaldermatology.com/conferences/scale-2023/treating-non-melanoma-skin-cancer-whats-new-and-exciting/20201/Dermatologists have a host of new tools for treating advanced basal and squamous cell carcinomas. Todd Schlesinger, MD, discusses hedgehog pathway inhibitors and immunotherapy and their growing role in treating non-melanoma skin cancers.How Reviews Impact Your Practice Today and Tomorrow
https://practicaldermatology.com/topics/practice-management/how-reviews-impact-your-practice-today-and-tomorrow/19892/Are you harnessing the power of patient reviews? It has never been more important to generate quality reviews from real people. In this video, Ekwa Marketing explores the factors that drive positive reviews. And the opportunities presented by this platform to grow loyalty and attract new patients.First Cell-Based Gene Therapy for RDEB
https://practicaldermatology.com/series/dermwire-tv/first-cell-based-gene-therapy-for-rdeb/35742/In this week's DermwireTV, the FDA approves the first cell-based gene therapy for recessive dystophic epidermolysis bullosa (RDEB); a new acne scar treatment using focal point technology is cleared in the US; and in our “Updates on Skin Cancer” feature, we hear about the advantages of 40-GEP testingEmbracing Photodynamic Therapy (PDT) in Your Practice
https://practicaldermatology.com/series/pdt-in-practice/embracing-photodynamic-therapy-pdt-in-your-practice/20209/Dr. Neal Bhatia, Chief Medical Editor of Practical Dermatology, provides updates in photodynamic therapy (PDT) and how to incorporate its techniques and technologies into everyday practice. Dr. Bhatia also provides some practical advice on using the therapy and on protecting yourself and your patienHow Incyte Is Following the Science to Address Unmet Needs in Immune-Mediated Skin Conditions
https://practicaldermatology.com/topics/infections-infectious-disease/how-incyte-is-following-the-science-to-address-unmet-needs-in-immune-mediated-skin-conditions/19945/Ahmad Naim, MD, Vice President of US Medical Affairs at Incyte, shares how the company’s discovery expertise in immunology is fueling research aimed at delivering innovative medicines that address the unmet needs of people living with immune-mediated dermatologic conditions, including atopic dermati